Tag: Takeda
Takeda Loses Antitrust Appeal Over Patent Listing
Takeda Pharmaceutical must face antitrust litigation over its alleged scheme to delay generic versions of the diabetes drug Actos by exaggerating the scope of...
Takeda, Endo Face New Pay-To-Delay Suit
The operator of Kinney Drugs retail chain sued Takeda Pharmaceutical and Endo International over claims that the pharmaceutical manufacturers allegedly engaged in a pay-to-delay...
Takeda Wants 2nd Circuit To Toss Actos Antitrust Suit
Takeda Pharmaceuticals on Wednesday, April 7, urged a federal appeals court to toss lawsuits accusing it of delaying generic versions of its blockbuster diabetes...
Japan’s Takeda Sells $2.3B Drugs Subsidiary To Blackstone
Takeda Pharmaceutical is selling its subsidiary in Japan focused on consumer healthcare to US investment fund Blackstone Group.
The deal, announced Monday, August 24, by...
EU Regulators Allow Takeda To Buy Shire
Japan’s Takeda Pharmaceutical will not be required to sell a biologic drug, a concession made to address EU antitrust concerns over its 2018 bid...
Takeda To Divest Products To Brazil’s Hypera For $825M
Brazil’s Hypera Pharma announced on Monday, March 2, that it has signed a contract to buy a portfolio of 18 pharmaceutical products from Japan’s...
US: Takeda loses bid to DQ Baker Botts in antitrust case
Takeda Pharmaceutical Company on Thursday, June 6, lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals in a lawsuit...
Japan: Takeda wins shareholder approval for US$59B Shire acquisition
Takeda Pharmaceutical has won shareholder approval to finance its £46 billion (US$58.6 billion) purchase of Shire, paving the way for Japan’s largest corporate takeover...
EU: Commission approves acquisition of Shire by Takeda, subject to conditions
The European Commission has approved under the EU Merger Regulation the acquisition of Shire by Takeda Pharmaceutical Company. The decision is conditional on the...
EU: Takeda considers selling experimental drug to win EU approval
Pharmaceutical company Takeda is talking with the European Commission about selling an experimental inflammatory bowel disease drug to help close its US$62 billion takeover...
